Our CRISPR
Technology

SNIPR Biome is pioneering the development of precision medicines for vulnerable patients with difficult-to-treat conditions using CRISPR technology for microbial gene therapy. We use our technology to selectively and precisely kill target bacteria, while leaving the rest of the microbial community intact and unharmed. SNIPR Biome utilizes the natural bacterial CRISPR-based adaptive immune system in a programmable way to kill target bacteria based on their specific genomes. Our drugs are next-generation antibiotics harbouring DNA-based CRISPR-Guided Vectors™ (CGV™ Technology) that cause double-stranded breaks in bacterial genomes and ultra-rapid killing in a matter of minutes, allowing rapid response in acute settings.